133 results
DEFA14A
RVNC
Revance Therapeutics Inc
21 Mar 24
Additional proxy soliciting materials
4:09pm
Materials
Soliciting Material Pursuant to § 240.14a-12
Revance Therapeutics, Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
8-K
EX-1.1
RVNC
Revance Therapeutics Inc
5 Mar 24
Other Events
5:08pm
is authorized to disclose to any persons the U.S. federal and state income tax treatment and tax structure of the potential transaction and all materials
8-K
EX-10.2
ovm5nd9
28 Feb 24
Provides Corporate Update
4:07pm
8-K
EX-10.1
7zafgc9zzsow5hga4
28 Feb 24
Provides Corporate Update
4:07pm
8-K
EX-10.1
r53qjiigb2x51w5p urv
13 Feb 24
Departure of Directors or Certain Officers
4:28pm
8-K
EX-3.1
msj6y4
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:04pm
DEFA14A
g4wb6o
31 Mar 23
Additional proxy soliciting materials
4:08pm
8-K
EX-1.1
jsq9qwizn si0r5
13 Sep 22
Other Events
9:55pm